Raymond James Trust N.A. Has $158,000 Stake in Medical Properties Trust, Inc. (NYSE:MPW)

Raymond James Trust N.A. lowered its position in Medical Properties Trust, Inc. (NYSE:MPW) by 15.0% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 32,160 shares of the real estate investment trust’s stock after selling 5,683 shares during the period. Raymond James Trust N.A.’s holdings in Medical Properties Trust were worth $158,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Covestor Ltd lifted its position in shares of Medical Properties Trust by 94.8% in the 1st quarter. Covestor Ltd now owns 4,505 shares of the real estate investment trust’s stock worth $95,000 after purchasing an additional 2,192 shares during the period. Harbour Investments Inc. lifted its position in shares of Medical Properties Trust by 1,247.4% during the 4th quarter. Harbour Investments Inc. now owns 4,608 shares of the real estate investment trust’s stock valued at $51,000 after acquiring an additional 4,266 shares during the period. First Manhattan Co. acquired a new position in shares of Medical Properties Trust during the 1st quarter valued at $98,000. Advisors Asset Management Inc. acquired a new position in shares of Medical Properties Trust during the 3rd quarter valued at $28,000. Finally, Northwestern Mutual Wealth Management Co. lifted its position in shares of Medical Properties Trust by 43.9% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 5,402 shares of the real estate investment trust’s stock valued at $60,000 after acquiring an additional 1,649 shares during the period. Institutional investors and hedge funds own 71.79% of the company’s stock.

Wall Street Analyst Weigh In

MPW has been the topic of a number of research reports. StockNews.com downgraded shares of Medical Properties Trust from a “hold” rating to a “sell” rating in a research report on Thursday, February 22nd. Royal Bank of Canada lowered their price objective on shares of Medical Properties Trust from $8.00 to $5.00 and set an “outperform” rating on the stock in a report on Tuesday, February 20th. Mizuho lowered their price objective on shares of Medical Properties Trust from $9.00 to $7.00 and set a “neutral” rating on the stock in a report on Wednesday, January 3rd. JPMorgan Chase & Co. lowered their price objective on shares of Medical Properties Trust from $8.00 to $5.00 and set an “underweight” rating on the stock in a report on Wednesday, November 29th. Finally, KeyCorp restated a “sector weight” rating on shares of Medical Properties Trust in a report on Friday, January 5th. Six research analysts have rated the stock with a sell rating, four have assigned a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $6.59.

Medical Properties Trust Stock Up 18.6 %

Medical Properties Trust stock opened at $4.72 on Thursday. The firm has a 50 day moving average price of $3.80 and a 200-day moving average price of $4.52. The company has a quick ratio of 2.26, a current ratio of 2.26 and a debt-to-equity ratio of 1.32. Medical Properties Trust, Inc. has a twelve month low of $2.92 and a twelve month high of $10.74. The company has a market capitalization of $2.83 billion, a P/E ratio of -5.02, a P/E/G ratio of 1.11 and a beta of 1.19.

Medical Properties Trust Company Profile

Medical Properties Trust, Inc is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospital real estate with 441 facilities and approximately 44,000 licensed beds as of September 30, 2023.